HomeORKA • NASDAQ
add
Oruka Therapeutics Inc
Previous close
$40.80
Day range
$37.76 - $40.73
Year range
$5.49 - $42.88
Market cap
1.95B USD
Avg Volume
447.37K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 34.43M | 13.57% |
Net income | -29.58M | -14.75% |
Net profit margin | — | — |
Earnings per share | -0.45 | 8.16% |
EBITDA | -34.40M | -13.54% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 337.04M | -10.28% |
Total assets | 488.62M | 23.38% |
Total liabilities | 16.69M | 20.94% |
Total equity | 471.93M | — |
Shares outstanding | 49.54M | — |
Price to book | 4.24 | — |
Return on assets | -17.25% | — |
Return on capital | -17.88% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -29.58M | -14.75% |
Cash from operations | -22.59M | 6.16% |
Cash from investing | -22.02M | 93.88% |
Cash from financing | 298.00K | -99.26% |
Net change in cash | -44.32M | 87.11% |
Free cash flow | -24.04M | -33.35% |
About
Founded
2024
Headquarters
Website
Employees
68
